A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
about
NMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional EffectsThe Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan InteractionsEngineering chemoattractant gradients using chemokine-releasing polysaccharide microspheres.A chemokine self-presentation mechanism involving formation of endothelial surface microstructuresMultiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.Emerging concepts and approaches for chemokine-receptor drug discovery.Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry.Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammationRole of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model.Glycosaminoglycan analogs as a novel anti-inflammatory strategyThe dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerizationModulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivoChemokines: novel targets for breast cancer metastasisVascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammationAnti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β.Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization.CCL2 nitration is a negative regulator of chemokine-mediated inflammation.The blood-brain barrier, chemokines and multiple sclerosisChemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in functionA beginner's guide to chemokines.G protein-coupled receptors in rheumatology.Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes.Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles.Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.Difference in Th1 and Th17 lymphocyte adhesion to endothelium.Fungal Mimicry of a Mammalian Aminopeptidase Disables Innate Immunity and Promotes Pathogenicity.The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.Crucial biological functions of CCL7 in cancer.The expression and correlation between chemokine CCL7 and ABCE1 in non-small cell lung cancer
P2860
Q27660108-CA9DCA5B-5911-419E-A8C7-B401BF1FC356Q27681101-BB484CC1-3AC9-4CED-9DBF-6437B284F015Q28115376-FE3D65AB-B083-4F3D-892F-8D2D1A998189Q30502668-CA6778CF-B9FF-4105-BBF1-53582B8429D3Q30540297-D7E7BF35-F72D-4D9B-930C-B5EDCE5A8BA1Q33652172-F518E49D-1AD5-4F16-9157-F667BC9C4450Q33763369-FEE3B259-0D16-470E-B45B-C59730613311Q33885243-4BD54206-6170-4C33-B923-65201E18A9D2Q34363360-807FD9E5-A9B4-46E2-9BB5-03D3E16AE456Q35528569-D651BD3D-953A-45D2-9476-EF3D109D0478Q35849570-8F40D416-117B-4214-B800-94EF52D018E5Q36238379-02EEB2E5-AE47-4B6B-9A41-F956841529D9Q36321143-1B19F319-628E-444D-86C0-C9338F15F1E0Q36530735-DB282FBE-54C4-4464-8A8D-444B906BBA60Q36611135-64E70A7F-5977-4FD3-92E9-12125296AC87Q36918688-7AD567C3-C539-4065-B0C6-15E4F6DE434CQ37293908-984C82C3-A44F-4546-962C-2650498C9073Q37470294-9DABDF00-31BF-4CF6-8E4F-38021E611BC3Q37591422-28A4F31F-7E33-4650-8F28-EFAEA593D90AQ37637122-953A145A-2219-4DD1-9339-D72B0AADD280Q37698743-5F71AC84-419A-417C-ABE8-E59FA3911D3CQ37778548-95B6B408-34AA-4657-8C9D-BFBD6730F744Q37827607-CB2670DE-6333-4835-B90A-2274293CC2F9Q38008721-5FADD89E-7422-41F6-9807-5CECACD0C05FQ38209549-40D64E43-65AC-4734-9FC1-F85769AFF38CQ39368250-3D7E46E1-75F5-48DC-A6FF-8CD3CC7EF710Q39964534-CF4F149A-C0EE-421F-AD44-F78A27BEABF0Q40232348-EE7AA185-D84B-4C8D-B0E7-C528B02A648AQ40558418-9F49E1A3-CE52-4EF3-ADD6-B9096F50705DQ40774687-0311B964-A3AC-4F5C-8C70-47B5088CA62AQ47207922-0FB6E5F5-5B2C-4CB0-91D1-B1DC9385ABD9Q51735732-0DF29949-7205-4586-BDD5-7CE8A9D5B347Q55364341-9F39776F-5B02-4DC0-9C48-55DE386B9728Q58802779-92DC9339-1FDB-4776-902F-17B71491E2C5
P2860
A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A non-glycosaminoglycan-bindin ...... emokine-mediated inflammation.
@en
type
label
A non-glycosaminoglycan-bindin ...... emokine-mediated inflammation.
@en
prefLabel
A non-glycosaminoglycan-bindin ...... emokine-mediated inflammation.
@en
P2093
P1476
A non-glycosaminoglycan-bindin ...... emokine-mediated inflammation.
@en
P2093
Ghada Malik
Helen Robertson
John A Kirby
Julie H Wain
P304
P356
10.4049/JIMMUNOL.175.2.1257
P407
P577
2005-07-01T00:00:00Z